Literature DB >> 16497990

Advanced oxidation protein products accelerate atherosclerosis through promoting oxidative stress and inflammation.

Shang Xi Liu1, Fan Fan Hou, Zhi Jian Guo, Ryoji Nagai, Wei Ru Zhang, Zhi Qiang Liu, Zhan Mei Zhou, Mei Zhou, Di Xie, Guo Bao Wang, Xun Zhang.   

Abstract

OBJECTIVE: Increased level of plasma advanced oxidation protein products (AOPPs) has been found in patients with uremia and nonuremic subjects with coronary artery disease. This study was conducted to test the hypothesis that AOPPs play a causal role in atherosclerosis. METHODS AND
RESULTS: Hypercholesterolemic (0.5% wt/wt diet) or normal rabbits received either repeated intravenous injections of AOPPs modified rabbit serum albumin (AOPPs-RSA) or unmodified RSA for 8 weeks. Compared with RSA- or vehicle-treated hypercholesterolemic rabbits, AOPPs-RSA-treated animals displayed increased atherosclerotic plaque area oxidized low-density lipoprotein (oxLDL) deposition, macrophage infiltration, and smooth muscle cell proliferation. Aortic sections from AOPPs-RSA-treated normal rabbits showed significant focal intima proliferation and mild Oil-Red-O staining lipid deposition in the affected areas, a phenomenon not observed in the RSA- or vehicle-treated controls. Plasma AOPPs levels in AOPPs-treated groups significantly increased in both hypercholesterolemic and normal rabbits compared with their relevant controls. Close correlations were found between plasma levels of AOPPs and the parameters of oxidative stress, eg, oxLDL and thiobarbituric acid reactive substances levels, or glutathione peroxidase activity. A highly significant correlation was also observed between plasma AOPPs and tumor necrosis factor (TNF)-alpha levels.
CONCLUSIONS: This study provides in vivo evidence for a causal relationship between chronic AOPPs accumulation and atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16497990     DOI: 10.1161/01.ATV.0000214960.85469.68

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  47 in total

1.  Advanced oxidation protein products promote NADPH oxidase-dependent β-cell destruction and dysfunction through the Bcl-2/Bax apoptotic pathway.

Authors:  Min Liang; Aiqing Li; Aiju Lou; Xifang Zhang; Youyuan Chen; Lei Yang; Yumin Li; Shenglin Yang; Fan Fan Hou
Journal:  Lab Invest       Date:  2017-03-06       Impact factor: 5.662

Review 2.  IgA nephropathy and oxidative stress: news on clinically evaluated biomarkers hits the stage.

Authors:  Cheng Zhu; Peter R Mertens
Journal:  Int Urol Nephrol       Date:  2012-06-10       Impact factor: 2.370

3.  Assessment of oxidative, inflammatory, and fibrinolytic biomarkers and DNA strand breakage in hypercholesterolemia.

Authors:  Renata da Silva Pereira; Etiane Tatsch; Guilherme Vargas Bochi; Helena Kober; Thiago Duarte; Greice Franciele Feyh dos Santos Montagner; José Edson Paz da Silva; Marta Maria Medeiros Frescura Duarte; Ivana Beatrice Mânica da Cruz; Rafael Noal Moresco
Journal:  Inflammation       Date:  2013-08       Impact factor: 4.092

4.  Evaluation of oxidant-antioxidant status in overweight and morbidly obese Saudi children.

Authors:  Waleed H Albuali
Journal:  World J Clin Pediatr       Date:  2014-02-08

5.  Renal expression of advanced oxidative protein products predicts progression of renal fibrosis in patients with IgA nephropathy.

Authors:  Jun Wang; Min Liang; Jie Xu; Wei Cao; Guo B Wang; Zhan M Zhou; Jian W Tian; Nan Jia; Zhenhai Zhang; Jing Nie; Youhua Liu; Fan F Hou
Journal:  Lab Invest       Date:  2014-07-28       Impact factor: 5.662

6.  Plasma-advanced oxidation protein products are potent high-density lipoprotein receptor antagonists in vivo.

Authors:  Gunther Marsche; Sasa Frank; Andelko Hrzenjak; Michael Holzer; Sabine Dirnberger; Christian Wadsack; Hubert Scharnagl; Tatjana Stojakovic; Akos Heinemann; Karl Oettl
Journal:  Circ Res       Date:  2009-01-29       Impact factor: 17.367

7.  Increased non-enzymatic glycation of plasma proteins and hemoglobin in non-diabetic patients with acute myocardial infarction (MI).

Authors:  V Parthibane; N Selvaraj; V Sathiyapriya; Zachariah Bobby; Medha Rajappa
Journal:  J Clin Diagn Res       Date:  2013-11-11

8.  Advanced glycation end product receptor-1 transgenic mice are resistant to inflammation, oxidative stress, and post-injury intimal hyperplasia.

Authors:  Massimo Torreggiani; Huixian Liu; Jin Wu; Feng Zheng; Weijing Cai; Gary Striker; Helen Vlassara
Journal:  Am J Pathol       Date:  2009-09-24       Impact factor: 4.307

9.  Advanced oxidation protein products induce cardiomyocyte death via Nox2/Rac1/superoxide-dependent TRAF3IP2/JNK signaling.

Authors:  Anthony J Valente; Tadashi Yoshida; Robert A Clark; Patrice Delafontaine; Ulrich Siebenlist; Bysani Chandrasekar
Journal:  Free Radic Biol Med       Date:  2013-02-20       Impact factor: 7.376

Review 10.  Biomarkers of obesity and subsequent cardiovascular events.

Authors:  Salma Musaad; Erin N Haynes
Journal:  Epidemiol Rev       Date:  2007-05-10       Impact factor: 6.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.